Idiotypic-anti-idiotypic antibody interactions can be used in vivo to regul
ate the serum levels of specific radiolabeled antibodies. Anti-idiotypic an
tibodies can also be used as clearing agents for radiolabeled antibodies in
radioimmunolocalization and radioimmunotherapy. The present study describe
s the immunochemical interactions between the monoclonal idiotype (H7) and
three generated monoclonal anti-idiotypic antibodies (alpha H7:1, alpha H7:
35, and alpha H7:38). An unexpected variability in complex formation could
be demonstrated in vitro, revealing three different stable complex patterns
, i.e., low molecular weight 1:1 complexes, ladder formation with oligomeri
c, consecutively added constituents, and large linear polymeric complexes o
f high molecular weight. Within 24 h, the anti-idiotypes were able to cause
a significant decrease in total body radioactivity, and the antibody gener
ating a ladder formation (alpha H7:38) was found to be the most efficient a
t removing radiolabeled idiotypes from the circulation. It is concluded tha
t monoclonal antiidiotypic antibodies may be valuable tools in improving ra
dioimmunolocalization and radioimmunotargeting.